Australia, Dec. 11 -- Neurocrine Biosciences Inc., owns the trademark (2487776) for 'CRENESSITY' till Aug. 13, 2034.
Status: protected:
Registered/protected
Class: 44 [Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders.]
Type of Mark: Word
Date of Acceptance: Oct. 3
Registration Advertised: Dec. 10
For further details contact King & Wood Mallesons and P.C. Nadine H. Jacobson Fross Zelnick Lehrman & Zissu.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2487776.
Disclaimer: Curated by HT Syndication.
